{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-002052","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.231671+00:00","generated_at":"2026-05-29T05:06:46.154653+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Lipella Pharmaceuticals enters agreement for up to $6M Series B convertible preferred offering","bullets":["Offering of up to $6,000,000 in Series B non-voting convertible preferred stock; underwritten by Spartan Capital Securities.","Placement agent fee: 10% of gross proceeds in cash plus warrants for 10% of conversion shares at $1.00/share, 5-year term.","Separate consulting agreement with Spartan: $300,000 cash fee and 700,000 shares of Series C Preferred Stock for advisory services.","Series C Preferred Stock is junior to other preferred, pari passu with common, convertible 1:1 with 4.99% beneficial ownership limit.","Investors granted right to purchase additional $6M in a Mirror Offering within six months of registration effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-002052","json":"https://secwatch.observer/filing/0001753926-24-002052.json","markdown":"https://secwatch.observer/filing/0001753926-24-002052.md","text":"https://secwatch.observer/filing/0001753926-24-002052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002052/0001753926-24-002052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002052/g084587_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T05:06:46.154653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}